Effect of simvastatin (MK-733) on plasma triacylglycerol levels in rats

Biochemical Pharmacology

Volumn 41, Issue 8, 1991, Pages 1163-1172

  Sato, Akiko ^a   Watanabe, Keiko ^a   Fukuzumi, Hitoshi ^a   Hase, Kanako ^a   Ishida, Fumiaki ^a   Kamei, Toshio ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; LIPOPROTEIN LIPASE; SIMVASTATIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMAL; BODY WEIGHT; CLOFIBRATE; ENERGY INTAKE; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIVER; LOVASTATIN; MALE; MUSCLES; ORGAN WEIGHT; RATS; RATS, INBRED STRAINS; SIMVASTATIN; TRIGLYCERIDES;

EID: 0026013241     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(91)90654-N     Document Type: Article

References (43)

1. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin
2. Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and cholesterol-lowering agent
3. Regulation of HMG-CoA reductase
4. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative
5. Inhibitory effects of MK-733 on cholesterol synthesis in primary cultured rat hepatocytes
6. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells
7. Preventive effect of MK-733 (simvastatin), an inhibitor of HMG-CoA reductase, on hypercholesterolemia and atherosclerosis induced by cholesterol feeding in rabbits
8. Comparative effects of simvastatin (MK-733) and pravastatin (CS-514) on hypercholesterolemia induced by cholesterol feeding in rabbits
9. New developments in lipid-lowering therapy: The role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase
10. The clinical efficacy of lovastatin and MK-733—An overview
11. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia
12. Simvastatin (MK-733): A potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia
13. Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multiple center study group II)
14. Low-dose effects of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins with hypercholesterolemia
15. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
16. Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in rats
17. Lipolytic enzymes and plasma lipoprotein metabolism
18. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism
19. 2-like particles during lipolysis of very low density lipoproteins in vitro
20. 2
21. The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein-post-heparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals
22. Effects of ML-236B on cholesterol metabolism in mice and rats Lack of hypercholesterolemic activity in normal animals
23. Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors
24. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics
25. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions
26. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
27. Practical methods for plasma lipoprotein analysis
28. A selective decline of postheparin plasma hepatic triglyceride lipase in hypothyroid rats
29. A selective deficiency of triacylglycerol lipase in guinea pigs
30. A rapid assay for lipoprotein lipase
31. Use of fluorescamine for the estimation of protein in the presence of the detergent Triton X-100
32. Newman-Keuls test
33. The regulation of hepatic triglyceride metabolism by free fatty acids
34. Stimulation of hepatic cholesterol biosynthesis by oleic acid
35. Cholesterol is required for secretion of very-low-density lipoprotein by rat liver
36. Cholesterol is required for the secretion of the very-low-density lipoprotein: In vivo study
37. Lipoprotein lipase. Isolation and characterization of a second enzyme species from postheparin plasma
38. Lipoprotein lipase
39. Effect of nutritional status on rat adipose tissue, muscle and post-heparin plasma clearing factor lipase activities: Their relationship to triglyceride fatty acid uptake by fat-cells and to plasma insulin concentrations
40. Regulation of lipoprotein metabolism by endothelia lipolytic enzymes
41. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferase in rat liver
42. Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB)
43. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; Enhancement by clofibrate, a hypolipidemic drug